FDA Expands Indications for Senhance Surgery System
Share

With the promise of increased benefits of shorter hospital stays, less blood loss, less pain, fewer complications from surgery and a quicker return to normal activities for most patients, many hospitals and healthcare systems are embracing the use of robotic surgery systems.

Recently, the FDA granted 510(k) clearance for the Senhance Surgery System for use in laparoscopic inguinal hernia surgery and laparoscopic cholecystectomy. The system was previously cleared for use to assist in the accurate control of laparoscopic instruments for visualization and endoscopic manipulation of tissue including grasping, cutting, blunt and sharp dissection, approximation, ligation, electrocautery, suturing, mobilization and retraction in laparoscopic colorectal surgery, and laparoscopic gynecological surgery.

Additional information about the Senhance Surgery System can be found . A Hayes Technology Prognosis Overview on the Senhance Surgery System is available here.